• Explore /
  • Poster
  • / Utilization of tumor-informed circulating tumor DNA in detecting minimal residual disease and guiding adjuvant therapy in liver cancer.

Utilization of tumor-informed circulating tumor DNA in detecting minimal residual disease and guiding adjuvant therapy in liver cancer.

Abstract Poster

Authors

null

De-Zhen Guo

Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University), Ministry of Education, Shanghai, China

De-Zhen Guo , Shi-Yu Zhang , Zhu-Jun Gu , Shuang-Tao Zhou , Da-Wei Jin , Shuang Yang , Jia Fan , Jian Zhou , Xin-Rong Yang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer - Local-Regional Disease

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 4125)

DOI

10.1200/JCO.2024.42.16_suppl.4125

Abstract #

4125

Poster Bd #

105

Abstract Disclosures

Similar Posters

First Author: Derrian Cooley

First Author: Xianhai Mao

First Author: Susanna Slater

First Author: Xianhai Mao